Pre-acute hepadnaviral infection is associated with activation-induced apoptotic death of lymphocytes in the woodchuck (Marmota monax) model of hepatitis B

Developmental and Comparative Immunology

Volumn 34, Issue 9, 2010, Pages 999-1008

  Gujar, Shashi A ^a   Jenkins, Adam K M ^a   MacParland, Sonya A ^a   Michalak, Tomasz I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Apoptosis; Hepadnaviral infection; Immunity; T lymphocyte response; Viral hepatitis; Woodchuck (Marmota monax)

Indexed keywords

ACUTE HEPATITIS; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; HEPADNAVIRUS; HEPADNAVIRUS INFECTION; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MARMOTA MONAX; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCIURIDAE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WOODCHUCK HEPATITIS; WOODCHUCK HEPATITIS VIRUS;

HEPATITIS B VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS VIRUS;

EID: 77954088961     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2010.05.001     Document Type: Article

References (49)

1. Bertoletti A., Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003, 38:4-13.
2. Bertoletti A., Gehring A. Immune response and tolerance during chronic hepatitis B virus infection. Hepatol. Res. 2007, 37(Suppl. 3):S331-S338.
3. Blankenberg F.G., Tait J.F., Strauss H.W. Apoptotic cell death: its implications for imaging in the next millennium. Eur. J. Nucl. Med. 2000, 27:359-367.
4. Chang J.J., Lewin S.R. Immunopathogenesis of hepatitis B virus infection. Immunol. Cell Biol. 2007, 85:16-23.
5. Chisari F.V., Ferrari C. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 1995, 17:261-281.
6. Clerici M., Sarin A., Coffman R.L., Wynn T.A., Blatt S.P., Hendrix C.W., Wolf S.F., Shearer G.M., Henkart P.A. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:11811-11815.
7. Coffin C.S., Michalak T.I. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J. Clin. Invest. 1999, 104:203-212.
8. Diaz C., Schroit A.J. Role of translocases in the generation of phosphatidylserine asymmetry. J. Membr. Biol. 1996, 151:1-9.
9. Frank I., Budde C., Fiedler M., Dahmen U., Viazov S., Lu M., Dittmer U., Roggendorf M. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide. J. Virol. 2007, 81:7156-7163.
10. Gujar S.A., Jenkins A.K., Guy C.S., Wang J., Michalak T.I. Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnavirus in the woodchuck model of hepatitis B virus infection. J. Virol. 2008, 82:6992-7008.
11. Gujar S.A., Michalak T.I. Flow cytometric quantification of T cell proliferation and division kinetics in woodchuck model of hepatitis B. Immunol. Invest. 2005, 34:215-236.
12. Gujar S.A., Michalak T.I. Characterization of bioactive recombinant woodchuck interleukin-2 amplified by RLM-RACE and produced in eukaryotic expression system. Vet. Immunol. Immunopathol. 2006, 112:183-198.
13. Gujar S.A., Michalak T.I. Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the woodchuck model of hepatitis B virus infection. J. Virol. 2009, 83:3861-3876.
14. Guy C.S., Mulrooney-Cousins P.M., Churchill N.D., Michalak T.I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 2008, 82:8579-8591.
15. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:3466-3469.
16. Hirsch R.L., Griffin D.E., Johnson R.T., Cooper S.J., Lindo de Sariano I., Roedenbeck S., Vaisberg A. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin. Immunol. Immunopathol. 1984, 31:1-12.
17. Hodgson P.D., Michalak T.I. Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 2001, 34:1049-1059.
18. Kadowaki N., Antonenko S., Lau J.Y., Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 2000, 192:219-226.
19. Kawai T., Akira S. Innate immune recognition of viral infection. Nat. Immunol. 2006, 7:131-137.
20. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004, 11:97-107.
21. Lecoeur H., Oliveira-Pinto L.M., Gougeon M.L. Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods 2002, 265:81-96.
22. Lu Y., Xu Y., Yang D., Kemper T., Roggendorf M., Lu M. Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes. Cytokine 2008, 41:127-135.
23. Menne S., Cote P.J. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J. Gastroenterol. 2007, 13:104-124.
24. Menne S., Cote P.J., Butler S.D., Toshkov I.A., Gerin J.L., Tennant B.C. Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection. Hepatology 2007, 45:614-622.
25. Meyaard L., Schuitemaker H., Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?. Immunol. Today 1993, 14:161-164.
26. Michalak T.I. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol. Rev. 2000, 174:98-111.
27. Michalak T.I. Immunology of hepatitis B virus. Hepatitis Prevention and Treatment 2004, 87-105. Birkhäuser Verlag, Basel. J.M. Colacino, B.A. Heinz (Eds.).
28. Michalak T.I., Mulrooney P.M., Coffin C.S. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J. Virol. 2004, 78:1730-1738.
29. Michalak T.I., Pardoe I.U., Coffin C.S., Churchill N.D., Freake D.S., Smith P., Trelegan C.L. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999, 29:928-938.
30. Michalak T.I., Pasquinelli C., Guilhot S., Chisari F.V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 1994, 93:230-239.
31. Mueller D.L. Mechanisms maintaining peripheral tolerance. Nat. Immunol. 2010, 11:21-27.
32. Mulrooney-Cousins P.M., Michalak T.I. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J. Gastroenterol. 2007, 13:5682-5686.
33. Mulrooney-Cousins P.M., Michalak T.I. Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity. J. Virol. 2008, 82:7540-7550.
34. Nakamura I., Nupp J.T., Rao B.S., Buckler-White A., Engle R.E., Casey J.L., Gerin J.L., Cote P.J. Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3epsilon with applications for the detection of RNA expression in tissues by RT-PCR assay. J. Med. Virol. 1997, 53:85-95.
35. Neuveut C., Wei Y., Buendia M.A. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 2010, 52:594-604.
36. Niewiesk S., Gotzelmann M., ter Meulen V. Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4251-4255.
37. Raimondo G., Allain J.-P., Brunetto M.R., Buendia M.-A., Chen D.-S., Colombo M., et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J. Hepatol. 2008, 49:652-657.
38. Rathmell J.C., Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002, 109(Suppl.):S97-S107.
39. Rinaldo C.R., Carney W.P., Richter B.S., Black P.H., Hirsch M.S. Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J. Infect. Dis. 1980, 141:488-495.
40. Roger P.M., Durant J., Ticchioni M., Halfon P., Breittmayer J.P., Brignone C., Chaillou S., Dunais B., Dellamonica P., Bernard A. Apoptosis and proliferation kinetics of T cells in patients having experienced antiretroviral treatment interruptions. J. Antimicrob. Chemother. 2003, 52:269-275.
41. Rouse B.T., Horohov D.W. Immunosuppression in viral infections. Rev. Infect. Dis. 1986, 8:850-873.
42. Schmid I., Uittenbogaart C.H., Giorgi J.V. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry 1994, 15:12-20.
43. Sciutto E., Fragoso G., Baca M., De lC V., Lemus L., Lamoyi E. Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infect. Immun. 1995, 63:2277-2281.
44. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31:1-9.
45. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 1995, 184:39-51.
46. Wallace M., Waterman P.M., Mitchen J.L., Djavani M., Brown C., Trivedi P., Horejsh D., Dykhuizen M., Kitabwalla M., Pauza C.D. Lymphocyte activation during acute simian/human immunodeficiency virus SHIV (89.6PD) infection in macaques. J. Virol. 1999, 73:10236-10244.
47. Wang J., Michalak T.I. Comparison of biological activity of recombinant woodchuck interferon gamma and tumor necrosis factor alpha produced in baculovirus and Escherichia coli expression systems. Cytokine 2005, 30:22-34.
48. Wieland S., Thimme R., Purcell R.H., Chisari F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6669-6674.
49. World Health Organization Hepatitis B 2008, World Health Organization, Geneva, Switzerland, (Fact sheet no. 204). (accessed 10.04.10).